Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.22.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 111,032 $ 19,077
Restricted cash 5,182 4,982
Accounts receivable, net of allowance for doubtful accounts of $4,284 and $3,919 at December 31, 2021 and 2020, respectively 142,473 107,800
Prepaid expenses and other current assets 18,583 18,221
Total current assets 277,270 150,080
Property and equipment, net 11,127 17,486
Intangible assets, net 389,483 448,816
Goodwill 819,538 820,032
Other non-current assets 26,344 17,238
Total assets 1,523,762 1,453,652
Current liabilities    
Accounts payable 13,688 24,608
Accrued expenses and other current liabilities 75,294 56,809
Accrued salaries and payroll 29,280 23,125
Derivative instruments, short-term 16,662 18,258
Debt, current portion 8,350 8,350
Total current liabilities 143,274 131,150
Debt, long-term portion 688,683 1,013,397
Derivative instruments, long-term 11,444 35,317
Tax receivable agreement liability 210,639 0
Deferred taxes 14,765 13,567
Other non-current liabilities 9,240 3,334
Total liabilities 1,078,045 1,196,765
Commitments and contingent liabilities (Note 14)
Preferred stock, $0.001 par value, authorized 100,000,000 shares; none issued and outstanding as of December 31, 2021 0 0
Common stock, value, issued 79 590,711
Additional paid in capital 793,382 15,360
Accumulated deficit (360,364) (339,061)
Accumulated other comprehensive income (loss) 12,620 (10,123)
Total stockholders’ equity 445,717 256,887
Total liabilities and stockholders’ equity $ 1,523,762 $ 1,453,652